Written Question·Department of Health and Social Care·UIN 59052

Drugs: Prices

Tabled: 11 June 2025

Answered: 19 June 2025

Question

Kit Malthouse

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the (a) voluntary scheme for branded medicines pricing, access and growth and (b) statutory scheme payment rates on attracting pharmaceu

Answer

Ashley Dalton

Life sciences is a key growth-driving sector and is a core part of our modern Industrial Strategy. The 2024 Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) introduced, for the first time, an approximately £400 million industry-funded VPAG...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 59052) →